Squier Flashcards
Megakaryocyte regulation
Platelets can bind THPO to down regulate platelet formation
Platelet activation
ET damage causes collagen exposure (and vWF)
Platelet adheres to form plug (vWF)
Platelet aggregation via GP to fibrin
Platelet activation releases ADP and TXA2 to increase GP expression
vWF
Between ET and BM
Crosslinks collagen and platelets
Binds to FVIII in Plasma
ADP platelet release
ADP binding activates scramblase, resulting in phosphatidylserine (PS) on outer membrane (creates negative surface charge to stimulate intrinsic pathway of blood coagulation)
ASA inhibits what
COX1/2
Prevents Arachidonic acid to PGH2 formation
Cloting cascade
F7 binds F10——F10a acts to converts prothrombin to thrombin
Thrombin cleaves fibrinogen to fibrin
What does Thrombin activate in the extrinsic pathway?
Converts fibrinogin to fibrin
Further activate F7 to feed forward rxn
Activate F13 which causes soft clot to cross linked fibrin clot
Also activates F5 which increases prothrombin cleavage by 300,000 fold
Factor 13
Is a transglutamase which crosslinks glutamine to lysine to stabilize fibrin to make a hard clot
Activated by Thrombin, stabilized by Ca
Intrinsic pathway activation
Contact Activation of FXII Promotes Cleavage of Prekallikrein (PK) to Form Kallikrein (K)
Kallikrein Proteolytically Activates FXII to Form FXIIa
FXIIa Proteolytically Activates FXI to Form FXIa
FXIa Proteolytically Activates FIX to Form FIXa
Prekallikrein (PK) and FXI Circulate in Plasma in Complex with High-Molecular-Weight Kininogen (MMWK), which brings Zymogens in Contact with Bilayer (Lesion)
FIXa + FVIIIa (Proteolytically Activated by Thrombin) Activates FX (Integration Step Involving Common Pathway – Tissue Factor)
Vitamin K and Formation of Gamma Carboxyglutamic Acid (Calcium Binding Sites)
ɣ-Glutamyl Carboxylase Acts on Prothrombotic Factors Prothrombin, VII, IX, and X and on Antithrombotic Regulatory Proteins C and S.
Vitamin K Epoxide Reductase Reduces Vitamin Koxidized (KO) and is Blocked by Competitive Inhibitor Warfarin
Antithrombin III
(major targets are thrombin and Xa (also IX, XI, XII, thrombin, VIIa, kallikrein, and plasmin
Antithrombin
Blocks Active Site of Protease (e.g., Thrombin).
Serpin (serine protease inhibitor)
Stoichiometric Binding Occurs Through Reactive Site Loop (without Subsequent Hydrolysis; t½ = 3 days).
Heparin (highly sulfonated oligosaccharide) Stabilizes Complex to Favor Rapid Inactivation of Proteases.
Tissue Factor Pathway Inhibitor (TFPI)
TFPI Specifically Interacts with TF-FVIIa-FXa Complex.
Intracellular Degradation of FVIIa Following Internalization(Inactive Alone).
Thrombomodulin (TM)
TM is a Membrane Protein That Specifically Binds Thrombin
TM-Thrombin Complex Activates Protein C
Protein C in the Presence of Protein S Proteolytically Inactivates Factors Va and VIIIa
Clot Dissolution (Fibrinolysis)
Proteolysis (Inactivation) of Plasminogen Activatable Inhibitor
(PAI-1 and PAI-2)
Release of Inhibition of tissue type plasminogen activator
(t-PA)